Page last updated: 2024-08-22

rhenium and Graft-Versus-Host Disease

rhenium has been researched along with Graft-Versus-Host Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bornhäuser, M; Ehninger, G; Kotzerke, J; Schetelig, J; Schneider, S; Strumpf, A; Wunderlich, G1
Bornhäuser, M; Ehninger, G; Kiani, A; Kotzerke, J; Lauter, A; Platzbecker, U; Radke, J; Schetelig, J; Strumpf, A; Thiede, C; Wermke, M; Wunderlich, G1
Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R1
Boerner, AR; Bolte, O; Dammann, E; Eder, M; Franzke, A; Ganser, A; Gielow, P; Hertenstein, B; Hofmann, M; Knapp, W; Koenecke, C; Stadler, M1
Dietrich, JW; Hermann, S; Hoelzer, D; Klein, SA; Martin, H1

Trials

3 trial(s) available for rhenium and Graft-Versus-Host Disease

ArticleYear
Reduced-Intensity Conditioning Combined with (188)Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of In Vivo T Cell Depletion.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:10

    Topics: Aged; Alemtuzumab; Allografts; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Adhesion Molecules; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Prospective Studies; Radioimmunotherapy; Radioisotopes; Rhenium; T-Lymphocytes; Transplantation Conditioning; Vidarabine

2015
188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
    British journal of haematology, 2010, Volume: 148, Issue:6

    Topics: Adult; Aged; Antigens, CD; Antigens, Neoplasm; Cell Adhesion Molecules; Epidemiologic Methods; Erythrocyte Transfusion; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Male; Middle Aged; Platelet Transfusion; Radioimmunotherapy; Radioisotopes; Recurrence; Rhenium; Transplantation Conditioning

2010
Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.
    Blood, 2002, Mar-15, Volume: 99, Issue:6

    Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Cell Adhesion Molecules; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Radioimmunotherapy; Rhenium; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2002

Other Studies

2 other study(ies) available for rhenium and Graft-Versus-Host Disease

ArticleYear
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:10

    Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation

2003
Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia.
    International journal of hematology, 2008, Volume: 87, Issue:4

    Topics: Adult; Antibodies; Antigens, CD; Cell Adhesion Molecules; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Radioimmunotherapy; Radioisotopes; Recurrence; Rhenium; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Homologous

2008